A Phase 2, Open-Label, Non-Comparative, Multicenter Study to Evaluate the Safety and Tolerability, Efficacy and Pharmacokinetics of Isavuconazonium Sulfate for the Treatment of Invasive Aspergillosis or Invasive Mucormycosis in Pediatric Subjects
Clinical Trial Grant
Administered By
Pediatrics, Transplant and Cellular Therapy
Awarded By
Astellas Pharma Global Development, Inc
Start Date
February 18, 2020
End Date
March 1, 2024
Administered By
Pediatrics, Transplant and Cellular Therapy
Awarded By
Astellas Pharma Global Development, Inc
Start Date
February 18, 2020
End Date
March 1, 2024